high affinity iron permease is a key virulence factor required for Rhizopus oryzae pathogenesis

Rhizopus oryzae is the most common cause of mucormycosis, an angioinvasive fungal infection that causes more then 50% mortality rate despite first-line therapy. Clinical and animal model data clearly demonstrate that the presence of elevated available serum iron predisposes the host to mucormycosis....

Full description

Saved in:
Bibliographic Details
Published inMolecular microbiology Vol. 77; no. 3; pp. 587 - 604
Main Authors Ibrahim, Ashraf S, Gebremariam, Teclegiorgis, Lin, Lin, Luo, Guanpingsheng, Husseiny, Mohamed I, Skory, Christopher D, Fu, Yue, French, Samuel W, Edwards, John E. Jr, Spellberg, Brad
Format Journal Article
LanguageEnglish
Published Oxford, UK Oxford, UK : Blackwell Publishing Ltd 01.08.2010
Blackwell Publishing Ltd
Blackwell
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Rhizopus oryzae is the most common cause of mucormycosis, an angioinvasive fungal infection that causes more then 50% mortality rate despite first-line therapy. Clinical and animal model data clearly demonstrate that the presence of elevated available serum iron predisposes the host to mucormycosis. The high affinity iron permease gene (FTR1) is required for R. oryzae iron transport in iron-depleted environments. Here we demonstrate that FTR1 is required for full virulence of R. oryzae in mice. We show that FTR1 is expressed during infection in diabetic ketoacidosis (DKA) mice. In addition, we disrupted FTR1 by double cross-over homologous recombination, but multinucleated R. oryzae could not be forced to segregate to a homokaryotic null allele. Nevertheless, a reduction of the relative copy number of FTR1 and inhibition of FTR1 expression by RNAi compromised the ability of R. oryzae to acquire iron in vitro and reduced its virulence in DKA mice. Importantly, passive immunization with anti-Ftr1p immune sera protected DKA mice from infection with R. oryzae. Thus, FTR1 is a virulence factor for R. oryzae, and anti-Ftr1p passive immunotherapy deserves further evaluation as a strategy to improve outcomes of deadly mucormycosis.
Bibliography:http://hdl.handle.net/10113/47305
http://dx.doi.org/10.1111/j.1365-2958.2010.07234.x
Current address: Department of Microbiology, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Current address: Department of Microbiology, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt
ISSN:0950-382X
1365-2958
DOI:10.1111/j.1365-2958.2010.07234.x